Are retatrutide and Ozempic the same?

No. Ozempic is a brand name for semaglutide, a GLP-1 receptor agonist. Retatrutide is a different investigational molecule that activates GLP-1, GIP, and glucagon receptors. STEP 1 used semaglutide 2.4 milligrams in 1,961 adults (minus 14.9% at 68 weeks). TRIUMPH-1 is a retatrutide trial (2,339 people; company release up to 28.3% at 80 weeks on 12 milligrams). Those are separate trials of separate molecules. Retatrutide is not approved in the US, UK, Australia, or Canada on this site's national fields. This site does not rank them. Full records at /compounds/retatrutide and /compounds/semaglutide.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.